- Home
- ARBE vs ELTX Comparison
ARBE vs ELTX Comparison
Compare ARBE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBE | ELTX |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.0M | 134.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARBE | ELTX |
|---|---|---|
| Price | $1.86 | $8.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.63 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 6.2M | 80.5K |
| Earning Date | 03-04-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $667,000.00 | N/A |
| Revenue This Year | $69.79 | N/A |
| Revenue Next Year | $576.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $4.60 |
| 52 Week High | $3.37 | $12.62 |
Technical Indicators
Market Signals| Indicator | ARBE | ELTX |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 48.46 |
| Support Level | $1.16 | $7.81 |
| Resistance Level | $1.34 | $9.00 |
| Average True Range (ATR) | 0.16 | 0.50 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 86.06 | 35.53 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.